Corona in general

A team of researchers has demonstrated that the impact of the coronavirus disease 2019 (COVID-19) pandemic on excess mortality varied widely both between and within five European countries in 2020. // 25.10.2021

Keeping blood insulin levels within strict, healthy parameters is a daily goal for people with diabetes. But now, researchers from Japan have found that regulating blood insulin levels may even help lower the risk of getting COVID-19. // 25.10.2021

Researchers from EMIT bio have developed a biological light unit that can sterilize surfaces, killing SARS-CoV-2. // 25.10.2021

Researchers isolated single cells among individuals with and without prior infection with the SARS-CoV-2 vaccinated with BNT162b2 mRNA vaccine and compared the nature of the neutralizing antibody response against the original Wuhan virus and the subsequent variants. // 25.10.2021

New research published in the medRxiv* preprint server suggests that COVID-19 illness incurs a greater 90-day risk of venous thrombosis than the flu. However, arterial thrombosis remains a higher risk among people with the influenza virus. // 24.10.2021

Researchers discuss mutations in the NTD of the spike protein, which contains an antigenic “supersite” and is the target for nAbs. // 24.10.2021

Relatively young people wrestle with cognitive dysfunction for months

Amidst growing concerns on the use and potential benefits of convalescent plasma therapy, a research group in the United States has identified three human antibodies (Abs) that, when combined, demonstrate both robust viral suppressive properties against all tested severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Variants of Concern (VoC) in vitro and profound antiviral efficacy in vivo. // 21.10.2021

Nature Neuroscience - A novel study led by scientists in Lübeck, Germany, shows that SARS-CoV-2-infected brain endothelial cells undergo cell death due to the cleavage of NEMO by the viral... // 21.10.2021

In a recent study published on the bioRxiv* pre-print server, researchers from the Netherlands successfully trained honeybees (Apis mellifera) to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected minks (Neovison vison) using Pavlovian conditioning protocols. // 21.10.2021

The current study included the national response of Denmark and Sweden to the COVID-19 pandemic. // 21.10.2021

The symptoms and side effects of Covid-19 are scattered across a diagnostic spectrum. Some patients are asymptomatic or experience a mild immune response, while others report significant long-term illnesses, lasting complications, or suffer fatal outcomes. // 22.10.2021

A new study investigates how age influences SARS-CoV-2 replication, innate and adaptive immune responses. // 21.10.2021

Scientists estimate the effect of the pandemic on life expectancy at birth, at 65 years overall, as well as for individual populations.

New research suggests pneumonia in COVID-19 patients is linked to viral-induced changes in the brain. MRI scans revealed 57.9% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients had recent brain lesions. // 20.10.2021

The Yamagata flu virus, one of four flu viruses we're vaccinated against each year, hasn't been recorded anywhere in the world since April 2020. // 20.10.2021

Nature Reviews Immunology - Individuals with asymptomatic COVID-19 can transmit the virus and may be at risk of long-term disease. // 19.10.2021

The COVID-19 pandemic has led to more than 218 million infections and over 4.5 million deaths as of Sept. 3, 2021. Nonpharmaceutical interventions (NPIs), such as case isolation, quarantining contacts, and the complete lockdown of entire countries, were implemented in an effort to contain the pandemic. // 20.10.2021

A new study published on the medRxiv* preprint server used automated high content immunofluorescence microscopy (AHCIM) to assess the viability of such an approach to detect humoral immune responses against SARS-CoV-2 proteins. // 20.10.2021

The researchers followed international standards for systematic reviews, performed a comprehensive search, and gathered findings from 32 relevant studies published between 1936 and 2020. // 19.10.2021

A new study published in the journal Annals of Internal Medicine conducted systematic surveillance involving 2,397 HCWs who were fully vaccinated with the Pfizer-BioNTech BNT162 vaccine at the ASST Settelaghi hospitals, Italy, in February 2021. // 19.10.2021

In a recent study, researchers have used the predictive power of chest CT scans and plasma cytokines to predict death and severity in COVID-19 patients. // 20.10.2021

A new qualitative study examines the attitudes of school administrators, teachers, parents, and students towards the implementation of COVID-19 testing. // 19.10.2021

A study shows that mutations that SARS-CoV-2 has gained improve its advantage in the efficient translation of viral RNAs. // 19.10.2021

Researchers from the Washington University School Of Medicine have identified how a subset of variants of concern can escape neutralization by two neutralizing antibodies. // 19.10.2021

Researchers from Columbia University have been investigating the impact of the pandemic on the spread of non-coronavirus respiratory viral infections in New York. // 19.10.2021

In a recent study published in the journal PLOS Pathogens, scientists showed that nasal administration of a single-domain antibody (VHH), named K-874A, brought about inhibition of SARS-CoV-2 titers in infected lungs of Syrian hamsters. // 19.10.2021

A new study published on the bioRxiv* preprint aimed to identify highly immunoprevalent CD8 T-cell epitopes specific to SARS-CoV-2 that are confirmed to be endogenously processed and presented on frequently expressed HLA alleles. // 18.10.2021

The emergence of new SARS-CoV-2 variants that can spread rapidly and undermine vaccine-induced immunity threatens the end of the COVID-19 pandemic. The delta variant (B.1.617.2) emerged in India and subsequently spread globally within a short time period. Also in Germany, almost all recent infections are due to this variant. // 18.10.2021

According to a recent study, among unvaccinated people, reinfection with SARS-CoV-2 could happen as soon as 3 months after contracting the virus. // 18.10.2021